Joan Shaw
Hoofd Techniek/Wetenschap/O&O bij BELLUS HEALTH
Profiel
Joan E.
Shaw is currently the Vice President-Clinical Operations at BELLUS Health, Inc. Prior to this, she worked as the Senior Director-Clinical Operations at AtheroNova, Inc. She completed her undergraduate degree at the University of Delaware and her graduate degree at West Chester University of Pennsylvania.
Actieve functies van Joan Shaw
Bedrijven | Functie | Begin |
---|---|---|
BELLUS HEALTH | Hoofd Techniek/Wetenschap/O&O | 01-03-2020 |
Eerdere bekende functies van Joan Shaw
Bedrijven | Functie | Einde |
---|---|---|
ATHERONOVA INC. | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Joan Shaw
University of Delaware | Undergraduate Degree |
West Chester University of Pennsylvania | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
AtheroNova, Inc.
AtheroNova, Inc. Pharmaceuticals: MajorHealth Technology AtheroNova, Inc. operates as biotechnology company. The company engages in the research and development, marketing, and sale of pharmaceutical preparations and pharmaceutical intellectual property. It develops intellectual property that uses certain pharmacological compounds for the treatment of atherosclerosis, which is the primary cause of various cardiovascular diseases. The company was founded by Giorgio Zadini and Filiberto Zadini in 1997 and is headquartered in Irvine, CA. | Health Technology |
BELLUS Health, Inc.
BELLUS Health, Inc. Pharmaceuticals: MajorHealth Technology BELLUS Health, Inc. is a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of cough hypersensitivity and other hypersensitization disorders. Its product BLU-5937, is being developed for the treatment of chronic cough and chronic pruritus, or chronic itch. The company was founded on June 17, 1993 and is headquartered in Laval, Canada. | Health Technology |